UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042461
Receipt number R000048466
Scientific Title An International, Stepped-Wedge, Cluster-Randomized Trial Investigating the 0/1-hour Algorithm in Suspected Acute Coronary Syndrome in Asia:The rational of the DROP-Asian ACS study
Date of disclosure of the study information 2021/01/01
Last modified on 2023/11/19 16:48:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An International, Stepped-Wedge, Cluster-Randomized Trial Investigating the 0/1-hour Algorithm in Suspected Acute Coronary Syndrome in Asia:The rational of the DROP-Asian ACS study

Acronym

DROP-Asian ACS

Scientific Title

An International, Stepped-Wedge, Cluster-Randomized Trial Investigating the 0/1-hour Algorithm in Suspected Acute Coronary Syndrome in Asia:The rational of the DROP-Asian ACS study

Scientific Title:Acronym

DROP-Asian ACS

Region

Japan Asia(except Japan)


Condition

Condition

acute coronary syndrome

Classification by specialty

Cardiology Emergency medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Aim of this study is to quantify the impact of the use of the 0-1-hr/algorithm care on patient outcome and on costs in patients with chest pain presenting at the emergency room, as compared to usual care.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Others

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Primary outcome measure is the incidence of major adverse cardiac events (MACE), defined as the composite of cardiovascular death, new acute myocardial infarction (AMI) (type 1 or 2), unstable angina, or unexpected revascularization within 30 days (defined as any unplanned hospitalization with cardiac revascularization performed within the first 12 h after hospital admission in the context of ACS).

Key secondary outcomes

1) The proportion of patients managed as outpatients in order to quantify the efficacy of the investigated approaches in both arms.
2) The time from ED presentation to discharge in outpatients. The ED dwell time is derived from a common electronic patient record system used across all participating sites and is calculated as the time of the medical examination between the start time (sign-in time: defined as first medical contact with a MD or the triage nurse) and the end time (sign-off time: defined as the time when the attending physician has finished all medical procedures in the ED, including charting, with the patient to ready to leave the examination room either to be discharged or transferred to a different unit/ward within the hospital).
3) All-cause mortality (cardiovascular death and non-cardiovascular death) and new myocardial infarction (type 1 or 2) within 30 days after the index presentation.
4) Incidence of any cardiac revascularization within 30 days after the index presentation
5) Incidence of ED representation or hospitalization for unstable angina within 30 days after the index presentation.
6) Costs for healthcare resource use within 30 days following the index ED presentation are calculated based on the guidelines of each countries and cost tables for hospitals. Different costs are used for academic and general hospitals. For each patient, the costs are calculated based on the observed number and type of healthcare resources used.
7) Incidence of cardiac examinations (e.g., stress testing or coronary angiography) within 30 days after the index presentation. Adherence to the intervention condition (the 0/1-h algorithm) was evaluated.


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

Usual care

Interventions/Control_2

0-1 hr algorithm care

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

89 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients presenting to the emergency department.
Patients qualified for enrollment with initial presentation of clinically suspected ACS, based on a broad spectrum of symptoms including atypical symptoms and dyspnoea.
Written informed consent

Key exclusion criteria

ST elevation myocardial infarction
On chronic hemodialysis
A clear alternative case for the symptoms othe than ACS
Symptomatic patients with atrioventricular nodal re-entrant tachycardia demonstrate ST-segment depressions and relevant troponin kinetics. Because it is impossible to make a different diagnosis with type 1 MI, type 2 MI, MI with non-obstructive coronary arteries, or acute myocardial injury, we decided not to include these patients.
Acute heart failure due to already known non-coronary heart disease without suspected ACS.
Congestive heart failure with hypoxemia
Infection
Cariogenic shock
Dementia (Mini Mental State Examination; MMSE less than 20).
Confirmed primary pulmonary disease without suspected ACS.
Traumatic chest pain with preceded thorax injury without suspected ACS.
Inability or unwillingness to provide informed consent

Target sample size

4260


Research contact person

Name of lead principal investigator

1st name Kenji
Middle name
Last name Inoue

Organization

Juntendo University Nerima Hospital

Division name

Department of Cardiovascular and biology

Zip code

177-0033

Address

3-1-10, Nerimaku Takanodai, Tokyo, Japan

TEL

03-5923-3111

Email

keinoue@juntendo.ac.jp


Public contact

Name of contact person

1st name Kenji
Middle name
Last name Inoue

Organization

Juntendo University Nerima Hospital

Division name

Department of Cardiovascular and biology

Zip code

177-0033

Address

3-1-10, Nerimaku Takanodai, Tokyo, Japan

TEL

03-5923-3111

Homepage URL


Email

keinoue@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University Nerima Hospital
Department of Cardiovascular and biology

Institute

Department

Personal name



Funding Source

Organization

Grant-in-Aid for Scientific Research

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Roche Diagnostics K.K

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo University Nerima Hospital

Address

3-1-10, Nerimaku Takanodai, Tokyo, Japan

Tel

03-5923-3111

Email

keinoue@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学医学部附属練馬病院(東京都)


Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

3728

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 11 Month 15 Day

Date of IRB

2021 Year 06 Month 01 Day

Anticipated trial start date

2021 Year 04 Month 01 Day

Last follow-up date

2024 Year 07 Month 14 Day

Date of closure to data entry

2024 Year 07 Month 31 Day

Date trial data considered complete

2024 Year 08 Month 15 Day

Date analysis concluded

2024 Year 10 Month 30 Day


Other

Other related information



Management information

Registered date

2020 Year 11 Month 16 Day

Last modified on

2023 Year 11 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048466


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name